147 related articles for article (PubMed ID: 20553384)
1. Risk factors for developing a new venous thromboembolism in ambulatory patients with non-hematologic malignancies and impact on survival for gastroesophageal malignancies.
Shah MA; Capanu M; Soff G; Asmis T; Kelsen DP
J Thromb Haemost; 2010 Aug; 8(8):1702-9. PubMed ID: 20553384
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study.
Khorana AA; Francis CW; Culakova E; Lyman GH
Cancer; 2005 Dec; 104(12):2822-9. PubMed ID: 16284987
[TBL] [Abstract][Full Text] [Related]
3. Incidence and risk factors of venous thromboembolic events in lymphoma.
Zhou X; Teegala S; Huen A; Ji Y; Fayad L; Hagemeister FB; Gladish G; Vadhan-Raj S
Am J Med; 2010 Oct; 123(10):935-41. PubMed ID: 20920696
[TBL] [Abstract][Full Text] [Related]
4. The incidence of venous thromboembolism and its effect on survival among patients with primary bladder cancer.
Sandhu R; Pan CX; Wun T; Harvey D; Zhou H; White RH; Chew HK
Cancer; 2010 Jun; 116(11):2596-603. PubMed ID: 20336780
[TBL] [Abstract][Full Text] [Related]
5. Postoperative venous thromboembolism predicts survival in cancer patients.
Auer RA; Scheer AS; McSparron JI; Schulman AR; Tuorto S; Doucette S; Gonsalves J; Fong Y
Ann Surg; 2012 May; 255(5):963-70. PubMed ID: 22504195
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of glycemic parameters on venous thromboembolism risk prediction in gastrointestinal cancer.
Guadagni F; Riondino S; Formica V; Del Monte G; Morelli AM; Lucchetti J; Spila A; D'Alessandro R; Della-Morte D; Ferroni P; Roselli M
World J Gastroenterol; 2017 Jul; 23(28):5187-5195. PubMed ID: 28811713
[TBL] [Abstract][Full Text] [Related]
7. Incidence of Venous Thromboembolism in Patients With Newly Diagnosed Pancreatic Cancer and Factors Associated With Outcomes.
Frere C; Bournet B; Gourgou S; Fraisse J; Canivet C; Connors JM; Buscail L; Farge D;
Gastroenterology; 2020 Apr; 158(5):1346-1358.e4. PubMed ID: 31843588
[TBL] [Abstract][Full Text] [Related]
8. Hypercoagulabilty, venous thromboembolism, and death in patients with cancer. A Multi-State Model.
Posch F; Riedl J; Reitter EM; Kaider A; Zielinski C; Pabinger I; Ay C
Thromb Haemost; 2016 Apr; 115(4):817-26. PubMed ID: 26738412
[TBL] [Abstract][Full Text] [Related]
9. Venous thromboembolism (VTE) in patients with advanced gastric cancer: an Asian experience.
Kang MJ; Ryoo BY; Ryu MH; Koo DH; Chang HM; Lee JL; Kim TW; Kang YK
Eur J Cancer; 2012 Mar; 48(4):492-500. PubMed ID: 22169121
[TBL] [Abstract][Full Text] [Related]
10. Predictors of Venous Thromboembolism and Early Mortality in Lung Cancer: Results from a Global Prospective Study (CANTARISK).
Kuderer NM; Poniewierski MS; Culakova E; Lyman GH; Khorana AA; Pabinger I; Agnelli G; Liebman HA; Vicaut E; Meyer G; Shepherd FA
Oncologist; 2018 Feb; 23(2):247-255. PubMed ID: 28951500
[TBL] [Abstract][Full Text] [Related]
11. Venous Thromboembolism Is an Independent Predictor of Mortality Among Patients with Gastric Cancer.
Fuentes HE; Oramas DM; Paz LH; Wang Y; Andrade XA; Tafur AJ
J Gastrointest Cancer; 2018 Dec; 49(4):415-421. PubMed ID: 28634671
[TBL] [Abstract][Full Text] [Related]
12. A Validated Risk Score for Venous Thromboembolism Is Predictive of Cancer Progression and Mortality.
Kuderer NM; Culakova E; Lyman GH; Francis C; Falanga A; Khorana AA
Oncologist; 2016 Jul; 21(7):861-7. PubMed ID: 27125754
[TBL] [Abstract][Full Text] [Related]
13. Venous thromboembolism risk prediction in ambulatory cancer patients: clinical significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio.
Ferroni P; Riondino S; Formica V; Cereda V; Tosetto L; La Farina F; Valente MG; Vergati M; Guadagni F; Roselli M
Int J Cancer; 2015 Mar; 136(5):1234-40. PubMed ID: 25042739
[TBL] [Abstract][Full Text] [Related]
14. Venous Thromboembolism in Patients with Advanced Pancreatic Cancer Receiving Palliative Chemotherapy: Incidence and Effect on Prognosis.
Jeong HT; Bae JH; Kim HG; Han J
Korean J Gastroenterol; 2023 Mar; 81(3):109-120. PubMed ID: 36960693
[TBL] [Abstract][Full Text] [Related]
15. Survival patterns among venous thromboembolism patients with hematologic malignancies in Alberta, Canada from 2003 to 2015.
Alam AU; Karkhaneh M; Sun HL; Wu C
Thromb Res; 2021 Mar; 199():59-66. PubMed ID: 33429125
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Significance of Venous Thromboembolic Events in Disseminated Germ Cell Cancer Patients.
Gonzalez-Billalabeitia E; Castellano D; Sobrevilla N; Guma J; Hervas D; Luengo MI; Aparicio J; Sanchez-Muñoz A; Mellado B; Saenz A; Valverde C; Fernandez A; Margeli M; Duran I; Fernandez S; Sastre J; Ros S; Maroto P; Manneh R; Cerezuela P; Carmona-Bayonas A; Ayala de la Peña F; Luis Aguilar J; Rivera S; García Del Muro X; Germà-Lluch JR;
J Natl Cancer Inst; 2017 Jan; 109(4):. PubMed ID: 28122896
[TBL] [Abstract][Full Text] [Related]
17. Venous thromboembolism following L-asparaginase treatment for lymphoid malignancies in Korea.
Lee JH; Lee J; Yhim HY; Oh D; Bang SM
J Thromb Haemost; 2017 Apr; 15(4):655-661. PubMed ID: 28150907
[TBL] [Abstract][Full Text] [Related]
18. Microparticle-associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients.
Thaler J; Ay C; Mackman N; Bertina RM; Kaider A; Marosi C; Key NS; Barcel DA; Scheithauer W; Kornek G; Zielinski C; Pabinger I
J Thromb Haemost; 2012 Jul; 10(7):1363-70. PubMed ID: 22520016
[TBL] [Abstract][Full Text] [Related]
19. Impact of venous thromboembolism on mortality of elderly Medicare patients with stage III colon cancer.
Hanna N; Bikov KA; McNally D; Onwudiwe NC; Dalal M; Mullins CD
Oncologist; 2012; 17(9):1191-7. PubMed ID: 22767876
[TBL] [Abstract][Full Text] [Related]
20. Venous thromboembolic events in T-cell lymphoma patients: Incidence, risk factors and clinical features.
Lan Y; Guan J; Zhu J; Wang J; Li M; Sun C; Sun F; Huang J; Lu S; Zhang Y
Leuk Res; 2021 Apr; 103():106537. PubMed ID: 33631621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
